Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Chinese EV battery leader CATL plans a $4 billion IPO in Hong Kong set for May 20, 2023. The company, a major supplier for ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Chinese EV battery giant CATL aims to raise $4 billion in its Hong Kong listing scheduled for May 20, said a statement filed ...

The move signals strong momentum for Hong Kong's IPO market, despite the ongoing global economic uncertainties fueled by ...

As trade restrictions tighten across the U.S. and EU, and as global technology rivalries deepen, CATL's ambitions stretch ...

This week, CATL, a leading domestic lithium battery company, launched its Hong Kong IPO, heating up the lithium battery sector.